Commonwealth Equity Services’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$39.4K Sell
13,083
-4,000
-23% -$11.3K ﹤0.01% 4321
2026
Q1
$41.3K Hold
17,083
﹤0.01% 4216
2025
Q4
$74.5K Hold
17,083
﹤0.01% 4141
2025
Q3
$72K Hold
17,083
﹤0.01% 4126
2025
Q2
$49K Hold
17,083
﹤0.01% 4156
2025
Q1
$46K Buy
17,083
+7,000
+69% +$26.3K ﹤0.01% 4072
2024
Q4
$24K Sell
10,083
-3,484
-26% -$9.27K ﹤0.01% 4031
2024
Q3
$32K Buy
13,567
+455
+3% +$1K ﹤0.01% 3971
2024
Q2
$26K Buy
+13,112
New +$44.6K ﹤0.01% 3954

Other funds holding GNLX

Commonwealth Equity Services's GNLX Position: Q2 2026 in Review

Commonwealth Equity Services reduced its Genelux (GNLX) stake by 23% in Q2 2026, selling an estimated $11.3K and leaving 13,083 shares worth $39.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4321.

Commonwealth Equity Services first reported a position in GNLX in Q2 2024 and has held it in 9 quarters since. The position peaked at $74.5K in Q4 2025. 72 funds tracked by Wall St. Rank hold GNLX as of Q2 2026.

  • Commonwealth Equity Services held 13,083 shares of Genelux worth $39.4K as of Q2 2026.
  • Commonwealth Equity Services sold 4,000 Genelux shares in Q2 2026, an estimated $11.3K.
  • Genelux made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #4321 holding.
  • Commonwealth Equity Services first reported a position in Genelux in Q2 2024 and has held it in 9 quarters since.
  • Commonwealth Equity Services's Genelux position peaked at $74.5K in Q4 2025.
  • 72 funds tracked by Wall St. Rank held Genelux as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.